Panacea Biotec Limited (BOM:531349)

India flag India · Delayed Price · Currency is INR
535.35
+1.00 (0.19%)
At close: Jun 19, 2026
Market Cap32.85B +1.1%
Revenue (ttm)6.40B +14.4%
Net Income-53.70M
EPS-0.88
Shares Out n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume21,961
Open537.60
Previous Close534.35
Day's Range532.20 - 563.00
52-Week Range293.10 - 647.50
Betan/a
AnalystsHold
Price Target69.00 (-87.11%)
Earnings DateMay 30, 2026

About Panacea Biotec

Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Pharmaceutical formulations & Nutrition segments. The company’s product portfolio includes prescription products in various therapeutic areas, such as oncology, diabetes, gastro-intestinal care, nephrology, orthopedics, pain management, and fever; cold and cough; and betacoronavirus... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1984
Employees 2,149
Stock Exchange Bombay Stock Exchange
Ticker Symbol 531349
Full Company Profile

Financial Performance

In fiscal year 2026, Panacea Biotec's revenue was 6.40 billion, an increase of 14.43% compared to the previous year's 5.59 billion. Losses were -53.70 million, -35.84% less than in 2025.

Financial Statements

News

Pharma sector stocks rises today, June 18: Wockhardt up 2.86%, Natco Pharma gains 2.38%, Panacea Biotech rises 2.01%

Pharma stocks traded broadly in positive territory on June 18, 2026, during the early morning session, with most stocks posting gains. The broader market was largely flat, with the Nifty…

3 days ago - Business Upturn

Pharma sector stocks today, June 17: Aurobindo Pharma gains 2.26%, Panacea Biotech falls 1.80%, Cipla down 0.32%

Pharma stocks traded mixed on June 17, 2026, during the early morning session, with gains and losses spread across the sector. The broader market was positive, with the Nifty 50…

4 days ago - Business Upturn

Pharma sector stocks today, June 16: Sudeep Pharma up 3.09%, Panacea Biotech gains 0.89%, Indoco Remedies falls 1.13%

Pharma stocks traded mixed on June 16, 2026, during the early morning session, with modest gains and losses spread across the sector. The broader market was positive, with the Nifty…

5 days ago - Business Upturn

Pharma sector stocks rise today, June 12: Panacea Biotech gains 2.50%, Wockhardt rises 2.24%, Natco Pharma up 1.36%

Pharma stocks traded broadly in positive territory on June 12, 2026, during the early morning session, with most stocks posting gains. The broader market was also strong, with the Nifty…

9 days ago - Business Upturn

Pharma sector stocks today, June 10: Panacea Biotech falls 8.09%, Wockhardt declines 1.47%, Alembic Pharma up 1.02%

Pharma stocks traded mixed on June 10, 2026, during the early morning session, with gains and losses spread across the sector. The broader market was positive, with the Nifty 50…

11 days ago - Business Upturn

Pharma sector stocks today, June 9: Panacea Biotech surges 9.11%, Divis Laboratories up 3.46%, Ajanta Pharma gains 1.86%

Pharma stocks traded largely in positive territory on June 9, 2026, during the morning session, with most stocks posting gains. The broader market was stable, with the Nifty 50 up…

12 days ago - Business Upturn

Panacea Biotec shares price jumps over 7% after launch of global dengue vaccine project DENSTAR

Panacea Biotec shares jumped more than 7% in early trade on Tuesday after the company announced the launch of the DENSTAR project, a major international initiative aimed at advancing the…

12 days ago - Business Upturn

Panacea Biotec launches DENSTAR project to advance dengue vaccine in Africa

Panacea Biotec has announced the launch of the DENSTAR project, aimed at advancing the licensure of its tetravalent live-attenuated dengue vaccine, DengiAll®, in sub-Saharan Africa and facilitating it...

12 days ago - Business Upturn

Panacea Biotec reports dematerialisation of 6.11 crore shares in May 2026

Panacea Biotec has reported the dematerialisation of a total of 6,11,05,526 shares as of 31 May 2026. This includes 5,39,04,650 shares under the National Securities Depository Limited (NSDL) and 72,00...

16 days ago - Business Upturn

Pharma sector stocks today, June 5: Panacea Biotech up 6.14%, Wockhardt falls 6.49%, Natco Pharma down 1.79%

Pharma stocks traded mixed on June 5, 2026, during the late morning session, with a majority of stocks posting gains while a handful remained under selling pressure. The broader market…

16 days ago - Business Upturn

Pharma sector stocks today, June 4: Panacea Biotech up 7.24%, Wockhardt gains 3.09%, Natco Pharma falls 1.63%

Pharma stocks traded mixed on June 4, 2026, during the early morning session, with several stocks posting gains while others remained under mild selling pressure. The broader market was relatively…

17 days ago - Business Upturn

Panacea Biotec appoints Krishan Kumar Jalan as independent director for PBPL

Panacea Biotec has announced the appointment of Mr. Krishan Kumar Jalan as an additional non-executive independent director of its wholly owned subsidiary, Panacea Biotec Pharma Limited (PBPL). The ap...

23 days ago - Business Upturn

Pharma sector stocks today, May 27: Panacea Biotech rises 2.83%, Wockhardt up 2.71%, Aurobindo Pharma down 0.17%

Pharmaceutical stocks traded mixed during the morning session on May 27, 2026. While some stocks posted decent gains, a few names saw mild selling pressure. The BSE Healthcare index rose…

25 days ago - Business Upturn

Pharma sector stocks today, May 21: Panacea Biotech up 1.57%, Aurobindo Pharma jumps 1.37%, Torrent Pharma gains 1.48%

Pharmaceutical stocks traded mixed on May 21, 2026, during the morning session. While some stocks posted decent gains, several others saw mild selling pressure. The BSE Healthcare index rose 0.58%…

4 weeks ago - Business Upturn

Panacea Biotec reports no shares dematerialised in April 2026

Panacea Biotec has announced that no shares were dematerialised during April 2026. The company confirmed this in its regulatory filing, citing compliance with Regulation 74(5) of the SEBI (Depositorie...

6 weeks ago - Business Upturn

Pharma sector stocks today, May 7: Wockhardt falls 4%, Panacea Biotec jumps 2.16%, Biocon up 1%

Pharma sector performance remained largely stable in early trading on May 7, 2026. The NIFTY PHARMA Index stood at 24,108.9, showing no change (down 0.0%). The broader S&P BSE HEALTHCARE…

6 weeks ago - Business Upturn

Pharma sector stocks today, April 20: Panacea Biotech falls 2.23%, Alembic Pharma down 2.20%, Strides Pharma gains 1.43%

Pharmaceutical sector stocks traded mixed in early trade on Monday, April 20, 2026, with most counters under mild pressure. The S&P BSE Healthcare Index declined 0.33% to 43,343.25, while the…

2 months ago - Business Upturn

Panacea Biotec secures Rs 20.79 crore contract for Td vaccine supply

Panacea Biotec has announced the receipt of a Letter of Award from the Central Medical Services Society (CMSS), under the Ministry of Health and Family Welfare, Government of India. The…

2 months ago - Business Upturn

Pharma sector stocks surge today, March 18: Alembic jumps 2.87%, Panacea Biotec up 2.84%, Gland Pharma rises 2.69%

The pharmaceutical sector stocks in India showed positive movement on March 18, 2026, during early trading hours, with many scrips recording gains on both BSE and NSE. The S&P BSE…

3 months ago - Business Upturn

India Close To Dengue Vaccine: All About The Phase 3 Trials And More

DengiAll, which is Panacea Biotec's tetravalent live-attenuated vaccine, uses weakened strains of all four DENV serotypes. As a single-dose shot, it simplifies administration compared to other multi-d...

4 months ago - NDTV

Panacea Biotec shares jump over 4% after completion of Dengue vaccine Phase III trial enrolment

Shares of Panacea Biotec Limited surged over 4% in early trade after the company announced a major milestone in the...

5 months ago - Business Upturn

Panacea Biotec CFO Devender Gupta resigns; last working day December 15

Panacea Biotec has informed the stock exchanges that its Chief Financial Officer and Head of Information Technology, Devender Gupta, has...

7 months ago - Business Upturn

Panacea Biotec secures Rs 127.2 crore order from Government of India for supply of bivalent oral polio vaccine

Panacea Biotec Ltd on Thursday announced that the Central Medical Services Society (CMSS), under the Ministry of Health and Family...

9 months ago - Business Upturn

Panacea Biotec shares rally sharply over 4% after securing contract worth Rs 315 crore from UNICEF

Panacea Biotec’s shares surged more than 4% following news of a significant international milestone. The company has received a Letter...

9 months ago - Business Upturn

Panacea Biotec bags order worth Rs 315 crore for supply of oral polio vaccine from UNICEF

Panacea Biotec Limited has announced a major international achievement, securing a Letter of Award from UNICEF for the long-term supply...

9 months ago - Business Upturn